Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion

Eri Miyagi1,2,3, Amy J. Andrew1,2,3, Sandra Kao1,2,3, Klaus Strebel1,2,3
1Laboratory of Molecular Microbiology, Viral Biochemistry Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0460
2National Institutes of Health, Bethesda, MD
3Viral Biochemistry Section, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4, Room 310, 4 Center Drive MSC 0460, Bethesda, MD 20892-0460.

Tóm tắt

HIV-1 Vpu enhances the release of virions from infected cells. Recent work identified Bst-2/CD317/tetherin as a host factor whose inhibitory activity on viral release is counteracted by Vpu. A current working model proposes that Bst-2 inhibits virus release by tethering viral particles to the cell surface. Here, we analyzed endogenous Bst-2 with respect to its effect on virus release from HeLa cells, T cells, and macrophages. We noted significant cell type-dependent variation in Bst-2 expression. Vpu caused a reduction in Bst-2 expression in transfected HeLa cells and long-term infected macrophages. However, Vpu expression did not result in cell surface down-modulation of Bst-2 or a reduction in intracellular Bst-2 expression in CEMx174 or H9 cells, yet virus replication in these cells was Vpu-responsive. Surprisingly, Bst-2 was undetectable in cell-free virions that were recovered from the surface of HeLa cells by physical shearing, suggesting that a tethering model may not explain all of the functional properties of Bst-2. Taken together we conclude that enhancement of virus release by Vpu does not, at least in CEMx174 and H9 cells, require cell surface down-modulation or intracellular depletion of Bst-2, nor does it entail exclusion of Bst-2 from viral particles.

Từ khóa


Tài liệu tham khảo

10.1126/science.3261888

10.1038/334532a0

10.1128/jvi.66.12.7193-7200.1992

10.1128/jvi.66.1.226-234.1992

10.1128/jvi.64.2.621-629.1990

10.1371/journal.ppat.0020039

10.1128/JVI.80.8.3765-3772.2006

10.1016/j.virol.2007.08.009

10.1128/jvi.63.9.3784-3791.1989

10.1073/pnas.86.13.5163

10.1111/j.1462-5822.2007.01101.x

10.1073/pnas.93.1.111

10.1128/jvi.70.10.7108-7115.1996

10.1016/S0014-5793(96)01146-5

10.1073/pnas.96.25.14336

10.1110/ps.37302

10.1128/jvi.70.2.809-819.1996

10.1073/pnas.2433165100

10.1099/0022-1317-76-11-2717

10.1016/S1097-2765(04)00183-2

10.1128/JVI.72.6.5189-5197.1998

10.1016/j.chom.2007.08.001

10.1016/j.chom.2008.03.001

10.1038/nm1778

10.1182/blood.V84.6.1922.1922

10.1006/bbrc.1999.0683

10.1016/0888-7543(95)80171-H

10.1034/j.1600-0854.2003.00129.x

10.1038/nature06553

10.1371/journal.ppat.0020107

10.1128/jvi.69.12.7699-7711.1995

10.1128/JVI.73.2.887-896.1999

10.1016/j.virol.2003.11.021

10.1016/j.virol.2008.06.033

10.1128/jvi.67.8.5056-5061.1993

10.1016/S1054-3589(07)55006-4

10.1074/jbc.274.47.33800

10.1084/jem.194.9.1299

10.1128/jvi.59.2.284-291.1986

MF Gruber, KA Weih, EJ Boone, PD Smith, KA Clouse, Endogenous macrophage CSF production is associated with viral replication in HIV-1-infected human monocyte-derived macrophages. J Immunol 154, 5528–5535 (1995).

10.1128/JVI.77.21.11398-11407.2003

10.1128/JVI.01734-08